Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00032370 · ClinicalTrials.gov registry record · NA
Does Prophylactic Coronary Artery Revascularization for High Risk Patients Reduce Long-term Risk of Mortality
A NA study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
- 510
- Enrollment target
NCT00032370: Completed NA study, sponsored by US Department of Veterans Affairs.
NCT00032370 is a NA study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 510 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00032370, a NA study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
- 510 participants
- Enrollment target
Study Summary
Although a number of sophisticated diagnostic tests have been shown to be helpful in identifying patients at high risk for perioperative cardiac complications, no study has addressed the most important question: Should prophylactic coronary revascularization be performed prior to elective vascular surgery? This study is designed to answer this question.
Interventions
- PROCEDURE Coronary artery bypass grafting (CABG)
- PROCEDURE Vascular surgery with best medical treatment
- PROCEDURE Percutaneous transluminal coronary angioplasty (PTCA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 510 participants |
| Start Date | 1997-08 |
| Est. Completion | 2004-05 |
| Phase | NA |
What the finished NCT00032370 record still lists
NCT00032370 is an interventional study that assigns participants to a tested intervention. The registered 510 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower).
The record links to 0 conditions, and to 3 interventions - of which Coronary artery bypass grafting (CABG) is the first listed.
NCT00032370 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00032370 about?
NCT00032370 is a clinical study titled "Does Prophylactic Coronary Artery Revascularization for High Risk Patients Reduce Long-term Risk of Mortality". Although a number of sophisticated diagnostic tests have been shown to be helpful in identifying patients at high risk for perioperative cardiac complications, no study has addressed the most important question: Should prophylactic coronary revascularization be performed prior to elective vascular s...
What is the current status of trial NCT00032370?
This trial is currently completed. It is a NA study. The enrollment target is 510 participants. The study started on 1997-08. Estimated completion is 2004-05.
What interventions are being tested in trial NCT00032370?
The interventions under investigation include: Coronary artery bypass grafting (CABG) (PROCEDURE), Vascular surgery with best medical treatment (PROCEDURE), Percutaneous transluminal coronary angioplasty (PTCA) (PROCEDURE).
Who is sponsoring clinical trial NCT00032370?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00032370's enrollment target sits among peer trials
510 192nd of 2000 higher than 1,809 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03922542 · 510 participants · Phase 2
Comparison of Standard vs. Accelerated Corneal Crosslinking
- NCT04634552 · 510 participants · Phase 2
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
- NCT05164744 · 510 participants
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
- NCT05451004 · 510 participants · Phase 3
SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia